BD 240765 - VDRL Antigen, 10 0.5 mL Vials, Serological Test Reagent for Syphilis Screening
The BD 240765 VDRL Antigen is a serological diagnostic reagent used in the Venereal Disease Research Laboratory test for the detection of non-treponemal antibodies associated with syphilis infection. Supplied in a pack of 10 vials containing 0.5 mL each, this antigen preparation supports standardized laboratory procedures for qualitative and quantitative syphilis screening.
Manufactured under the quality standards of BD, the reagent is designed to deliver reliable performance in clinical diagnostic laboratories and public health testing facilities.
Key Benefits
Supports detection of non-treponemal antibodies in patient serum or cerebrospinal fluid samples. Standardized antigen formulation ensures reliable and reproducible test reactions. Packaged in multiple vials to support routine laboratory workflows and maintain reagent stability. Designed for compatibility with established VDRL slide testing protocols.
Compatibility and Applications
The BD 240765 VDRL Antigen is compatible with standard VDRL slide testing procedures used in serology laboratories. It is widely used in hospital laboratories, public health laboratories, sexually transmitted infection testing centers, and research institutions.
Typical applications include screening for syphilis infection, monitoring disease progression, and evaluating treatment response through non-treponemal antibody detection.
Usage Guidelines
This reagent should be used only by trained laboratory professionals following validated serological testing protocols. Prior to testing, ensure the antigen reagent is prepared and handled according to the manufacturers instructions. Mix the antigen with patient samples on a VDRL slide and interpret flocculation reactions using appropriate laboratory equipment and procedures. Confirm reactive results with additional treponemal-specific tests as required.
Certifications, Safety Standards, and Regulatory Approvals
BD diagnostic reagents are manufactured under regulated quality systems designed to ensure product consistency, performance reliability, and compliance with laboratory standards. Quality control testing verifies antigen reactivity and stability before distribution.
Comparison with Competitor Products
Compared with non-standardized antigen reagents, BD VDRL antigen preparations are produced under controlled manufacturing processes to ensure consistent diagnostic performance. BD reagents are widely trusted in clinical laboratories due to their reliability and compatibility with established serological testing protocols.
Typical User Profile and Application Scenarios
This product is commonly used by clinical laboratory technologists, microbiologists, and public health professionals performing serological testing for sexually transmitted infections. It is particularly valuable in diagnostic laboratories conducting routine syphilis screening and monitoring.
Best Practices for Use and Maintenance
Store the antigen reagent at the recommended temperature as indicated on the product label. Avoid exposure to excessive heat or light. Mix gently before use and handle under appropriate laboratory conditions. Maintain proper reagent tracking, including lot numbers and expiration dates. Dispose of biological and chemical waste according to institutional safety guidelines.
Regulatory and Safety Information
Although diagnostic reagents are laboratory-use products rather than direct patient-use devices, they are manufactured under strict quality control systems to support reliable clinical testing. Proper handling, storage, and disposal according to laboratory biosafety and chemical safety protocols are essential.
How to Order
Ordering the BD 240765 VDRL Antigen 10 0.5 mL Vials is simple. Add the product to your cart and proceed through the secure checkout process. For bulk purchasing or additional assistance, contact CIA Medical customer service at (312) 275-5850.
